Cargando...
Safety of selective IL‐23p19 inhibitors for the treatment of psoriasis
Psoriasis is a chronic disease that requires long‐term treatment. Consequently, understanding the safety and tolerability of any potential treatment over time is critical to effective prescribing. The biologic agents currently available for the treatment of psoriasis target a number of different inf...
Gardado en:
| Publicado en: | J Eur Acad Dermatol Venereol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6771721/ https://ncbi.nlm.nih.gov/pubmed/31054215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.15653 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|